Therapeutic immunization protects dopaminergic neurons in a mouse model of Parkinson's disease
- PMID: 15197276
- PMCID: PMC438994
- DOI: 10.1073/pnas.0400569101
Therapeutic immunization protects dopaminergic neurons in a mouse model of Parkinson's disease
Abstract
Degeneration of the nigrostriatal dopaminergic pathway, the hallmark of Parkinson's disease, can be recapitulated in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-intoxicated mice. Herein, we demonstrate that adoptive transfer of copolymer-1 immune cells to MPTP recipient mice leads to T cell accumulation within the substantia nigra pars compacta, suppression of microglial activation, and increased local expression of astrocyte-associated glial cell line-derived neurotrophic factor. This immunization strategy resulted in significant protection of nigrostriatal neurons against MPTP-induced neurodegeneration that was abrogated by depletion of donor T cells. Such vaccine treatment strategies may provide benefit for Parkinson's disease.
Figures
![Fig. 1.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/438994/bin/zpq0250451980001.gif)
![Fig. 2.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/438994/bin/zpq0250451980002.gif)
![Fig. 3.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/438994/bin/zpq0250451980003.gif)
![Fig. 4.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/438994/bin/zpq0250451980004.gif)
![Fig. 5.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/438994/bin/zpq0250451980005.gif)
![Fig. 6.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/438994/bin/zpq0250451980006.gif)
Similar articles
-
Quantitative 1H magnetic resonance spectroscopic imaging determines therapeutic immunization efficacy in an animal model of Parkinson's disease.J Neurosci. 2005 Feb 16;25(7):1691-700. doi: 10.1523/JNEUROSCI.4364-04.2005. J Neurosci. 2005. PMID: 15716405 Free PMC article.
-
Exendin-4 protects dopaminergic neurons by inhibition of microglial activation and matrix metalloproteinase-3 expression in an animal model of Parkinson's disease.J Endocrinol. 2009 Sep;202(3):431-9. doi: 10.1677/JOE-09-0132. Epub 2009 Jul 1. J Endocrinol. 2009. PMID: 19570816
-
Cannabinoid receptor type 1 protects nigrostriatal dopaminergic neurons against MPTP neurotoxicity by inhibiting microglial activation.J Immunol. 2011 Dec 15;187(12):6508-17. doi: 10.4049/jimmunol.1102435. Epub 2011 Nov 11. J Immunol. 2011. PMID: 22079984
-
The parkinsonian models: invertebrates to mammals.Jpn J Pharmacol. 2000 Nov;84(3):237-43. doi: 10.1254/jjp.84.237. Jpn J Pharmacol. 2000. PMID: 11138723 Review.
-
Inflammatory response in Parkinsonism.J Neural Transm Suppl. 2009;(73):245-52. doi: 10.1007/978-3-211-92660-4_19. J Neural Transm Suppl. 2009. PMID: 20411782 Review.
Cited by
-
Interleukin-2 expands neuroprotective regulatory T cells in Parkinson's disease.NeuroImmune Pharm Ther. 2022 Jun 21;1(1):43-50. doi: 10.1515/nipt-2022-0001. eCollection 2022 Mar. NeuroImmune Pharm Ther. 2022. PMID: 38407500 Free PMC article.
-
Causal relationship between immune cells and neurodegenerative diseases: a two-sample Mendelian randomisation study.Front Immunol. 2024 Jan 29;15:1339649. doi: 10.3389/fimmu.2024.1339649. eCollection 2024. Front Immunol. 2024. PMID: 38348026 Free PMC article.
-
Immunization Effects of a Novel α-Synuclein-Based Peptide Epitope Vaccine in Parkinson's Disease-Associated Pathology.Vaccines (Basel). 2023 Dec 5;11(12):1820. doi: 10.3390/vaccines11121820. Vaccines (Basel). 2023. PMID: 38140224 Free PMC article.
-
Lipid-Lowering Drug Gemfibrozil Protects Mice from Tay-Sachs Disease via Peroxisome Proliferator-Activated Receptor α.Cells. 2023 Dec 8;12(24):2791. doi: 10.3390/cells12242791. Cells. 2023. PMID: 38132111 Free PMC article.
-
A simple protocol for isolating microglia from adult mouse brain.NeuroImmune Pharm Ther. 2023 Aug 2;2(3):293-300. doi: 10.1515/nipt-2023-0014. eCollection 2023 Sep. NeuroImmune Pharm Ther. 2023. PMID: 37885917 Free PMC article.
References
-
- Fahn, S. & Przedborski, S. (2000) Merritt's Neurology (Lippincott, Williams & Wilkins, New York).
-
- Dauer, W. & Przedborski, S. (2003) Neuron 39, 889-909. - PubMed
-
- Chen, H., Zhang, S. M., Hernan, M. A., Schwarzschild, M. A., Willett, W. C., Colditz, G. A., Speizer, F. E. & Ascherio, A. (2003) Arch. Neurol. (Chicago) 60, 1059-1064. - PubMed
-
- Gao, H. M., Liu, B., Zhang, W. & Hong, J. S. (2003) Trends Pharmacol. Sci. 24, 395-401. - PubMed
-
- McGeer, P. L., Itagaki, S., Boyes, B. E. & McGeer, E. G. (1988) Neurology 38, 1285-1291. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 NS38586/NS/NINDS NIH HHS/United States
- R01 AG021617/AG/NIA NIH HHS/United States
- P50 NS038370/NS/NINDS NIH HHS/United States
- P50 NS 38370/NS/NINDS NIH HHS/United States
- 1T32 NS07488/NS/NINDS NIH HHS/United States
- P01 MH64570/MH/NIMH NIH HHS/United States
- P20RR15635/RR/NCRR NIH HHS/United States
- P01 MH064570/MH/NIMH NIH HHS/United States
- R01 NS 42269/NS/NINDS NIH HHS/United States
- R37 NS036126/NS/NINDS NIH HHS/United States
- P01 NS011766/NS/NINDS NIH HHS/United States
- T32 NS007488/NS/NINDS NIH HHS/United States
- P20 RR015635/RR/NCRR NIH HHS/United States
- R01 NS042269/NS/NINDS NIH HHS/United States
- R01 NS038586/NS/NINDS NIH HHS/United States
- 2R37 NS36126/NS/NINDS NIH HHS/United States
- P01 NS11766/NS/NINDS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous